Active Positionality: Choice Points, Tensions, and Opportunities
American Journal of Evaluation · 31.07.2026
DOI: 10.1177/10982140261470684 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Evaluation, online erschienen am 31.07.2026. Verfasst von Tatiana E. Bustos und 1 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
Positionality encompasses multi-dimensional aspects of social identities that intersect across contexts. Positionality is dynamic, shaping, and nuancing how and to what extent identities are expressed in different contexts from the perspective of the evaluator and interest holders. In this manuscript, we discuss the intersectional qualities of positionality grounded in lived experiences with culturally responsive evaluation to demonstrate active positionality. We reflect on the unique benefits and burdens associated with active positionality that dictate how much and which aspects of our identities are expressed in projects impacting communities we identify with. We close with a call to action, providing evaluators with practical strategies to expand shared accountability for positionality to the collective, consider the role of healing and well-being, and expand their orientation on positionality to include decision points that drive vulnerability, authenticity, and risks with disproportionate impacts on evaluators with marginalized identities.
Zitieren
APA
Bustos, T. E., & Ayeni, O. O. (2026). Active Positionality: Choice Points, Tensions, and Opportunities. American Journal of Evaluation. https://doi.org/10.1177/10982140261470684
Vancouver
Bustos TE, Ayeni OO. Active Positionality: Choice Points, Tensions, and Opportunities. American Journal of Evaluation. 2026. doi:10.1177/10982140261470684
BibTeX
@article{Bustos2026,
author = {Bustos, Tatiana E. and Ayeni, Oyesola Oluwafunmilayo},
title = {Active Positionality: Choice Points, Tensions, and Opportunities},
journal = {American Journal of Evaluation},
year = {2026},
doi = {10.1177/10982140261470684}
}
EUVIMED